MorphoSys AG
MorphoSys AG, together with its subsidiaries, engages in the development and commercialization of therapeutics for patients suffering from various cancers in Europe, Asia, and the United States. The company's product pipeline includes Pelabresib that is in Phase 3 trials to treat myelofibrosis and thrombocythemia; Tulmimetostat, a product candidate in Phase 1/2 trials for the treatment of solid t… Read more
Market Cap & Net Worth: MorphoSys AG (MPSYF)
MorphoSys AG (PINK:MPSYF) has a market capitalization of $2.76 Billion ($2.76 Billion) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #26245 globally and #8894 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying MorphoSys AG's stock price $73.27 by its total outstanding shares 37662700 (37.66 Million).
MorphoSys AG Market Cap History: 2015 to 2024
MorphoSys AG's market capitalization history from 2015 to 2024. Data shows growth from $2.35 Billion to $2.76 Billion (1.52% CAGR).
MorphoSys AG Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how MorphoSys AG's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
6.48x
MorphoSys AG's market cap is 6.48 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $2.35 Billion | $106.22 Million | $14.90 Million | 22.12x | 157.69x |
| 2016 | $1.82 Billion | $49.74 Million | -$60.38 Million | 36.66x | N/A |
| 2017 | $3.59 Billion | $66.79 Million | -$69.83 Million | 53.75x | N/A |
| 2018 | $3.88 Billion | $76.44 Million | -$56.17 Million | 50.75x | N/A |
| 2019 | $5.20 Billion | $71.76 Million | -$103.01 Million | 72.43x | N/A |
| 2020 | $4.26 Billion | $327.70 Million | $97.89 Million | 13.00x | 43.53x |
| 2021 | $1.40 Billion | $179.60 Million | -$514.50 Million | 7.79x | N/A |
| 2022 | $534.06 Million | $278.27 Million | -$151.06 Million | 1.92x | N/A |
| 2023 | $1.54 Billion | $238.28 Million | -$189.73 Million | 6.48x | N/A |
Competitor Companies of MPSYF by Market Capitalization
Companies near MorphoSys AG in the global market cap rankings as of March 19, 2026.
Key companies related to MorphoSys AG by market ranking:
- 6969 (TW:6969): Ranked #26236 globally with a market cap of $16.96 Million USD ( NT$561.03 Million TWD).
- Bluecom Co. Ltd (KQ:033560): Ranked #26237 globally with a market cap of $16.95 Million USD ( ₩24.82 Billion KRW).
- Lii Hen Industries Bhd (KLSE:7089): Ranked #26246 globally with a market cap of $16.92 Million USD ( RM76.19 Million MYR).
- VULCAN MINLS (F:VM3): Ranked #26247 globally with a market cap of $16.91 Million USD ( €16.47 Million EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #26236 | 6969 | TW:6969 | $16.96 Million | NT$28.55 |
| #26237 | Bluecom Co. Ltd | KQ:033560 | $16.95 Million | ₩3165.00 |
| #26246 | Lii Hen Industries Bhd | KLSE:7089 | $16.92 Million | RM0.31 |
| #26247 | VULCAN MINLS | F:VM3 | $16.91 Million | €0.14 |
MorphoSys AG Historical Marketcap From 2015 to 2024
Between 2015 and today, MorphoSys AG's market cap moved from $2.35 Billion to $ 2.76 Billion, with a yearly change of 1.52%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2024 | $2.76 Billion | +78.71% |
| 2023 | $1.54 Billion | +189.14% |
| 2022 | $534.06 Million | -61.83% |
| 2021 | $1.40 Billion | -67.17% |
| 2020 | $4.26 Billion | -18.01% |
| 2019 | $5.20 Billion | +33.98% |
| 2018 | $3.88 Billion | +8.05% |
| 2017 | $3.59 Billion | +96.87% |
| 2016 | $1.82 Billion | -22.39% |
| 2015 | $2.35 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 20th, 2025 the market cap of MorphoSys AG was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.76 Billion USD |
| MoneyControl | $2.76 Billion USD |
| MarketWatch | $2.76 Billion USD |
| marketcap.company | $2.76 Billion USD |
| Reuters | $2.76 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.